Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02189174 |
| Title | Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | Yes |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | ESP | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Massachusetts General Hospital SC-9 | Boston | Massachusetts | 02114 | United States | Details | |
| Memorial Sloan Kettering SC-4 | New York | New York | 10017 | United States | Details | |
| Tennessee Oncology SC | Nashville | Tennessee | 37203 | United States | Details | |
| Novartis Investigative Site | Toronto | Ontario | M5G 1X6 | Canada | Details | |
| Novartis Investigative Site | Kashiwa | Chiba | 277 8577 | Japan | Details | |
| Novartis Investigative Site | Singapore | 169610 | Singapore | Details | ||
| Novartis Investigative Site | Barcelona | Catalunya | 08035 | Spain | Details |